 After surgery, an End of Study EoS visit will occur 30 days - 3 days after the subjects last intake of ODM-201. In case of ongoing protocol treatment-related AEsSAEs at the time of the EoS visit, monitoring of these events will continue as clinically indicated until a the events have resolved or b the events have reached a status which, in the Investigators opinion, is unlikely to resolve due to the nature of the condition andor the subjects underlying disease. 